AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
61 hedge funds and large institutions have $26.5M invested in AVEO Pharmaceuticals, Inc. in 2019 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
27% less capital invested
Capital invested by funds: $36.2M → $26.5M (-$9.62M)
Holders
61
Holding in Top 10
–
Calls
$2.42M
Puts
$1.29M
Top Buyers
| 1 | +$908K | |
| 2 | +$430K | |
| 3 | +$203K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$182K |
| 5 |
Two Sigma Investments
New York
|
+$64K |
Top Sellers
| 1 | -$1.67M | |
| 2 | -$443K | |
| 3 | -$134K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$101K |
| 5 |
Baird Financial Group
Milwaukee,
Wisconsin
|
-$83K |